Cargando…
p.R220L Is a Likely Pathogenic Novel GLA Gene Mutation Responsible for Fabry Disease
Autores principales: | Ali Barman, Hasan, Atıcı, Adem, Özyıldırım, Serhan, Ceylaner, Serdar, Dursun, Memduh, Mesut Doğan, Sait |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Turkish Society of Cardiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366415/ https://www.ncbi.nlm.nih.gov/pubmed/35552179 http://dx.doi.org/10.5152/AnatolJCardiol.2021.393 |
Ejemplares similares
-
The Relationship between Coronary Flow Reserve and the TyG Index in Patients with Gestational Diabetes Mellitus
por: Ozyildirim, Serhan, et al.
Publicado: (2023) -
The Prevalence of Fabry Disease Among Turkish Patients with Non-Obstructive Hypertrophic Cardiomyopathy: Insights from a Screening Study
por: Barman, Hasan Ali, et al.
Publicado: (2019) -
Difficulties in Diagnosing Fabry Disease in Patients with Unexplained Left Ventricular Hypertrophy (LVH): Is the Novel GLA Gene Mutation a Pathogenic Mutation or Polymorphism?
por: Aladağ, N, et al.
Publicado: (2023) -
Prognostic significance of temporal changes of lipid profile in COVID-19 patients
por: Barman, Hasan Ali, et al.
Publicado: (2021) -
Prognostic value of right ventricular strain pattern on ECG in COVID-19 patients
por: Barman, Hasan Ali, et al.
Publicado: (2021)